kidney disease Archive — Page 2 of 6
-
December 15, 2022
Nephrology society lauds Bock’s research on kidney development
Vanderbilt's Fabian Bock, MD, PhD, won two awards at the Basic Research Forum for Emerging Kidney Scientists, presented virtually by the American Society of Nephrology and American Physiological Society. -
October 27, 2022
Terker selected as VUMC Discovery Scholar in Health and Medicine
-
October 20, 2022
Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage
-
October 6, 2022
Kidney diseases research collaboration renewed
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases. -
August 25, 2022
Inflammatory driver of obesity
Blocking the EGF receptor signaling pathway in immune system macrophages represents a new target for improving insulin resistance in people with obesity. -
May 12, 2022
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. -
February 2, 2022
VUMC study raises hope for improving treatment of kidney disease
Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.